ribavirin has been researched along with Bacteremia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huarte, MP; Lacruz, B; Quispe, I; Tiberio, G; Torroba, L | 1 |
Diago, M; Peño, L; Plana, L; Urquijo, JJ | 1 |
Farkas, A; Halász, T; Horváth, G; Tolvaj, G | 1 |
3 other study(ies) available for ribavirin and Bacteremia
Article | Year |
---|---|
[Helicobacter cinaedi-associated bacteremia in hepatitis C patient under triple therapy].
Topics: Antiviral Agents; Bacteremia; Drug Therapy, Combination; Helicobacter; Helicobacter Infections; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Opportunistic Infections; Recombinant Proteins; Ribavirin | 2015 |
Difficult management of triple therapy for chronic hepatitis C in a patient on haemodialysis.
Topics: Anemia, Hemolytic; Antiviral Agents; Bacteremia; Blood Component Transfusion; Catheter-Related Infections; Drug Therapy, Combination; Glomerulonephritis; Graft Rejection; Hepatitis C, Chronic; Humans; Immunosuppression Therapy; Interferon-alpha; Kidney Failure, Chronic; Kidney Transplantation; Liver Cirrhosis; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Postoperative Complications; Recombinant Proteins; Renal Dialysis; Ribavirin; Staphylococcal Infections; Thrombocytopenia | 2017 |
[Side effect of pegylated-interferon treatment in chronic C hepatitis: agranulocytosis].
Topics: Agranulocytosis; Antiviral Agents; Bacteremia; Bone Marrow; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2006 |